Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 12/20 | 0.42 |
| ▸ | CTSS | P25774 | 4/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | SYK | P43405 | 1/20 | 0.38 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12336373 | 0.89 | CA1 (0.47) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL29323075 | 0.86 | CA1 (0.45) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL4598803 | 0.85 | CA1 (0.51) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL2714283 | 0.85 | CA1 (0.51) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL2075999 | 0.85 | CA1 (0.51) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL2293242 | 0.85 | CTSK (0.46) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL2290326 | 0.85 | CTSK (0.46) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL858081 | 0.85 | CTSK (0.46) | CA1CA2CA7CTSKCTSS | |
| Hydrochloric Acid SCHEMBL1459125 | 0.83 | CTSK (0.45) | CA1CA2CA7CTSKCTSS | |
| SCHEMBL2846888 | 0.83 | CA1 (0.50) | CA1CA2CA7CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239771-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | TAXIS PHARMACEUTICALS, INC. | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239771-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | ABCB11, ABCB1, SLC47A1 | CA1 4555/4885CA2 2096/4885CA7 2247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.